Skip to main content
HLS Therapeutics Inc. (TSX:HLS)
Canada flag Canada · Delayed Price · Currency is CAD
4.650
+0.010 (0.22%)
Apr 28, 2026, 4:00 PM EST

HLS Therapeutics Revenue

In the year 2025, HLS Therapeutics had annual revenue of $55.50M USD, down -1.98%. HLS Therapeutics had revenue of $15.20M in the quarter ending December 31, 2025, a decrease of -2.23%.

Revenue
$55.50M
Revenue Growth
-1.98%
P/S Ratio
1.91
Revenue / Employee
$652.94K
Employees
85
Market Cap
145.42M CAD

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202555.50M-1.12M-1.98%
Dec 31, 202456.62M-6.46M-10.23%
Dec 31, 202363.07M1.61M2.61%
Dec 31, 202261.47M1.46M2.43%
Dec 31, 202160.01M3.90M6.95%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ascend Wellness Holdings 686.36M
Charlotte's Web Holdings 68.41M
Grown Rogue International 44.46M
Medexus Pharmaceuticals 136.34M
BioSyent 43.05M
Cannara Biotech 113.01M
Auxly Cannabis Group 151.48M
Aurora Cannabis 373.12M
Revenue Rankings

HLS Therapeutics News

More News